A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer
Clinical trial NCT02640365 · COMPLETED
Trial details
- NCT number
- NCT02640365
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-18
- Primary completion
- 2016-12-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.